Category: ImplantsSyndicate content

Implants

Johnson & Johnson's DePuy wins first trial over Pinnacle hips

October 24, 2014 by MassDevice

A federal jury in Texas clears Johnson & Johnson's DePuy Pinnacle hip implant in the 1st bellwether product liability trial over the metal-on-metal device.

Johnson & Johnson's DePuy wins first trial over Pinnacle hips

BREAKING: Jury clears DePuy in 1st Pinnacle bellwether trial

October 23, 2014 by Brad Perriello

A federal jury in Texas reportedly clears Johnson & Johnson's DePuy Pinnacle hip implant in the 1st bellwether product liability trial over the metal-on-metal device.

BREAKING: Jury clears DePuy in 1st Pinnacle bellwether trial

UPDATED Oct. 23, 2014, with comment from DePuy.

Jury deliberations begin in first trial over DePuy's Pinnacle hips

October 22, 2014 by MassDevice

A jury begins deliberations in the 1st trial over DePuy Orthopaedics' Pinnacle metal-on-metal hip implant.

Jury deliberations begin in first trial over DePuy's Pinnacle hips

Medtronic's new line of spinal implants drops

October 20, 2014 by Brad Perriello

A new line of spinal implants from Medtronic makes its debut on the global stage.

Medtronic's new line of spinal implants drops worldwide

Medtronic (NYSE:MDT) said it's introduced a new line of spinal implants made of a titanium-plastic combination for interbody fusion procedures.

St. Jude chases MRI-friendly labeling for its CRM devices

September 22, 2014 by Arezu Sarvestani

St. Jude Medical lands European approval to market its Tendril STS and IsoFlex Optim leads as safe for MRI scanning, adding that the company's just getting started on a larger MRI-safe campaign.

E.U. regulators dub St. Jude's Tendril STS, IsoFlex Optim leads safe with MRI

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Study: CardioMEMs implanted heart monitor safe for renal failure patients

September 16, 2014 by Arezu Sarvestani

New data from CardioMEMs CHAMPION clinical trial shows that the company's implanted pulmonary artery pressure monitor helps reduce heart failure hospitalizations without compromising kidney function in patients with renal failure.

Study: CardioMEMS' implanted sensor safe for renal failure patients

St. Jude Medical (NYSE:STJ) subsidiary CardioMEMs touted new study results this week showing that its implanted heart monitor is safe and effective in patients with chronic kidney disease.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp